...
首页> 外文期刊>Nepalese Journal of Ophthalmology >Systemic association of newly diagnosed proliferative diabetic retinopathy among type 2 diabetes patients presented at a tertiary eye hospital of Nepal
【24h】

Systemic association of newly diagnosed proliferative diabetic retinopathy among type 2 diabetes patients presented at a tertiary eye hospital of Nepal

机译:在尼泊尔三级眼科医院就诊的2型糖尿病患者中新诊断的增生性糖尿病视网膜病变的系统性关联

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction: Proliferative diabetic retinopathy (PDR) is the leading cause of blindness among the diabetics. Objective: to study the systemic association of proliferative diabetic retinopathy. Materials and methods: A prospective, case-series study was conducted among the newly diagnosed proliferative diabetic retinopathy cases presenting at the Tilganga Institute of Ophthalmology (TIO) from January 2012 to January 2013. Diabetic retinopathy was classi?ed using the Early Treatment Diabetic Retinopathy Study criteria. Blood pressure, fasting and postprandial blood sugar, glycosylated hemoglobin, lipid pro?le, urine for microalbumin, urea, and creatinine were evaluated at the time of diagnosis. Results: A total of 104 type 2 diabetic patients with newly diagnosed PDR presented during the study period. Concurrent macular edema was present in 93 cases (89.42 %). The mean age was 56.96 ± 9.394 (range 32 - 78) years. Males and females comprised of 75.7 % and 24.3 % respectively. The majority (37.5 %) were involved in business, followed by government service (17.30 %), and housewives (16.34 %). Mean duration of diabetes was 11.42 ± 5.356 years (range 1 month - 26 years). Concurrent hypertension was found in 55.76 %, uncontrolled fasting and or postprandial blood sugar in 72.54 %, poor glycemic control (HbA1C > 7 %) in 73.97 %, abnormal lipid profile in 52.56 %, microalbuminuria in 67.85 %, and positive urine albumin in 50 % of the cases. Conclusion: Despite the short duration of diabetes, the concurrent hypertension, poor glycemic control, proteinuria and dyslipidemia were the main systemic associations for PDR at our clinical set-up. Awareness, identification and management of these systemic problems could reduce the rapid progression to PDR.
机译:简介:增生性糖尿病视网膜病变(PDR)是糖尿病患者失明的主要原因。目的:研究增生性糖尿病视网膜病变的系统性关联。材料和方法:2012年1月至2013年1月在蒂尔冈加眼科研究所(TIO)对刚诊断为增生性糖尿病性视网膜病的病例进行了前瞻性病例系列研究。使用早期治疗糖尿病性视网膜病对糖尿病性视网膜病进行分类。学习标准。诊断时评估血压,禁食和餐后血糖,糖基化血红蛋白,脂质分布,尿液中微量白蛋白,尿素和肌酐。结果:在研究期间,共有104例2型糖尿病伴新诊断的PDR。并发黄斑水肿93例(89.42%)。平均年龄为56.96±9.394岁(范围32-78)。男性和女性分别占75.7%和24.3%。大多数(37.5%)从事商业活动,其次是政府服务(17.30%)和家庭主妇(16.34%)。糖尿病的平均病程为11.42±5.356年(范围1个月-26年)。并发高血压占55.76%,空腹和/或餐后血糖失控占72.54%,血糖控制不佳(HbA1C> 7%)为73.97%,血脂异常为52.56%,微量白蛋白尿为67.85%,尿白蛋白阳性为50 %的情况。结论:尽管糖尿病持续时间短,但在我们的临床研究中,并发高血压,血糖控制不良,蛋白尿和血脂异常是PDR的主要系统性关联。对这些系统性问题的认识,识别和管理可能会减少向PDR的快速发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号